O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.47B
AUM Growth
-$1.57B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
145
New
Increased
Reduced
Closed

Top Buys

1
+$95.1M
2
+$76.2M
3
+$74M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$72.1M
5
LLY icon
Eli Lilly
LLY
+$66.8M

Top Sells

1
+$205M
2
+$143M
3
+$75.8M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$56.3M
5
BMY icon
Bristol-Myers Squibb
BMY
+$49.2M

Sector Composition

1 Healthcare 90.2%
2 Financials 0.22%
3 Technology 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$7.09M 0.07%
268,672
102
$7.01M 0.07%
116,425
103
$6.92M 0.07%
565
104
$6.28M 0.07%
2,276,648
105
$5.94M 0.06%
317,000
106
$5.75M 0.06%
42,440
107
$5.74M 0.06%
+256,800
108
$5.19M 0.05%
1,022,100
109
$5.19M 0.05%
241,250
110
$5.13M 0.05%
194,900
-195,100
111
$4.67M 0.05%
456,666
112
$4.45M 0.05%
1,740,000
113
$4.43M 0.05%
8,332
114
$4.23M 0.04%
197,859
+165,659
115
$4.12M 0.04%
222,223
116
$3.57M 0.04%
438,784
117
$3.43M 0.04%
578,300
-5,926,100
118
$3.23M 0.03%
69,800
-3,087,200
119
$2.85M 0.03%
53,300
120
$2.63M 0.03%
100,000
121
$2.22M 0.02%
322,043
122
$2.19M 0.02%
+184,800
123
$1.61M 0.02%
375
124
$1.29M 0.01%
39,620
125
$1.25M 0.01%
692,900
2 3 4
5
6